Wolfgang Garten

Author PubWeight™ 53.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 New low-viscosity overlay medium for viral plaque assays. Virol J 2006 3.92
2 Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol 2003 2.87
3 Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 2006 2.80
4 Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J Virol 2003 2.57
5 Crystal structure of the borna disease virus nucleoprotein. Structure 2003 2.30
6 Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor. EMBO Rep 2003 1.85
7 Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J 2004 1.73
8 Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett 2003 1.62
9 Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res 2004 1.54
10 Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. Virology 2007 1.44
11 Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol 2010 1.40
12 The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol J 2006 1.27
13 Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication. J Virol 2010 1.20
14 Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2. J Virol 2010 1.15
15 MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine 2009 1.13
16 Taxonomic reorganization of the family Bornaviridae. Arch Virol 2014 1.09
17 Lassa virus glycoprotein signal peptide displays a novel topology with an extended endoplasmic reticulum luminal region. J Biol Chem 2004 1.06
18 Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope. J Virol 2007 1.06
19 Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics. J Med Chem 2010 1.05
20 Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses. J Virol 2012 1.03
21 Viral protein determinants of Lassa virus entry and release from polarized epithelial cells. J Virol 2010 1.02
22 Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses: Lessons from the 2009 pandemic. Bioessays 2011 1.00
23 TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice. J Virol 2014 0.99
24 Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases. J Biol Chem 2012 0.98
25 The role of single N-glycans in proteolytic processing and cell surface transport of the Lassa virus glycoprotein GP-C. Virol J 2006 0.96
26 Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium. Pathog Dis 2013 0.94
27 Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants. PLoS Negl Trop Dis 2009 0.91
28 Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties. Proc Natl Acad Sci U S A 2009 0.91
29 Maturation cleavage within the ectodomain of Lassa virus glycoprotein relies on stabilization by the cytoplasmic tail. FEBS Lett 2010 0.87
30 Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation. Biochem J 2013 0.84
31 RNA induced polymerization of the Borna disease virus nucleoprotein. Virology 2009 0.84
32 Oligomerization and assembly of the matrix protein of Borna disease virus. FEBS Lett 2005 0.84
33 The hemagglutinin: a determinant of pathogenicity. Curr Top Microbiol Immunol 2014 0.83
34 Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections. Vaccine 2012 0.83
35 Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication. J Virol 2009 0.82
36 Activation of influenza A viruses by host proteases from swine airway epithelium. J Virol 2013 0.81
37 Identification of the amino terminal subunit of the glycoprotein of Borna disease virus. FEBS Lett 2002 0.81
38 The role of oligomerization for the biological functions of the arenavirus nucleoprotein. Arch Virol 2013 0.81
39 Maturation of Borna disease virus glycoprotein. FEBS Lett 2005 0.79
40 Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses. Vaccine 2011 0.78
41 Crystallization and preliminary X-ray analysis of the matrix protein of Borna disease virus. Acta Crystallogr D Biol Crystallogr 2002 0.77
42 Gangliosides are not essential for influenza virus infection. Glycoconj J 2006 0.77
43 Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT. Bioorg Med Chem Lett 2011 0.77
44 The microtubule motor protein KIF13A is involved in intracellular trafficking of the Lassa virus matrix protein Z. Cell Microbiol 2013 0.75